EXHIBIT 32.1

    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



      In connection  with the Quarterly  Report of Elite  Pharmaceuticals,  Inc.
(the  "Company") on Form 10-Q for the quarter ended June 30, 2005 filed with the
Securities  and Exchange  Commission  (the  "Report"),  I, Bernard  Berk,  Chief
Executive Officer of the Company,  certify, pursuant to 18 U.S. C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the  requirements of Section 13(a) of
      the Securities Exchange Act of 1934; and

      (2)   The  information  contained in the Report  fairly  presents,  in all
      material respects,  the consolidated financial condition of the Company as
      of the dates  presented and the  consolidated  result of operations of the
      Company for the periods presented.


                                    /s/ Bernard Berk
Date: August 15, 2005               -------------------------------------
                                    Bernard Berk
                                    Chief Executive Officer of
                                    Elite Pharmaceuticals, Inc.


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.